Zobrazeno 1 - 10
of 29
pro vyhledávání: '"David Pahan"'
Autor:
Renate A Richardus, Konrad van der Zwet, Anouk van Hooij, Louis Wilson, Linda Oskam, Roel Faber, Susan J F van den Eeden, David Pahan, Khorshed Alam, Jan Hendrik Richardus, Annemieke Geluk
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 11, Iss 12, p e0006083 (2017)
Despite elimination efforts, the number of Mycobacterium leprae (M. leprae) infected individuals who develop leprosy, is still substantial. Solid evidence exists that individuals living in close proximity to patients are at increased risk to develop
Externí odkaz:
https://doaj.org/article/cfc307281b7e431c925774b057fc75ee
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 5, Iss 5, p e1029 (2011)
BACKGROUND: Leprosy is remaining prevalent in the poorest areas of the world. Intensive control programmes with multidrug therapy (MDT) reduced the number of registered cases in these areas, but transmission of Mycobacterium leprae continues in most
Externí odkaz:
https://doaj.org/article/f46555ace47e49c5914027c67806f6ec
Autor:
Willemijn J Idema, Istvan M Majer, David Pahan, Linda Oskam, Suzanne Polinder, Jan Hendrik Richardus
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 4, Iss 11, p e874 (2010)
BACKGROUND: With 249,007 new leprosy patients detected globally in 2008, it remains necessary to develop new and effective interventions to interrupt the transmission of M. leprae. We assessed the economic benefits of single dose rifampicin (SDR) for
Externí odkaz:
https://doaj.org/article/3b6c019add6d420ba3eb010ab9228b0d
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 2, Iss 2, p e198 (2008)
BACKGROUND: The prevalence of previously undiagnosed leprosy (PPUL) in the general population was determined to estimate the background level of leprosy in the population and to compare this with registered prevalence and the known PPUL in different
Externí odkaz:
https://doaj.org/article/a9bb0439127f43ec9f2d9b530e243764
Autor:
Ron P Schuring, Jan H Richardus, Ewout W Steyerberg, David Pahan, William R Faber, Linda Oskam
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 2, Iss 8, p e283 (2008)
BACKGROUND: To validate and update a prediction rule for estimating the risk of leprosy-related nerve function impairment (NFI). METHODOLOGY/PRINCIPAL FINDINGS: Prospective cohort using routinely collected data, in which we determined the discriminat
Externí odkaz:
https://doaj.org/article/91901f9ed44642d9beecee11b04999e8
Publikováno v:
Leprosy Review. 90:399-417
Autor:
David Pahan, Khorshed Alam, M D Abdul Hamid Salim, Aung Kya Jai Maug, Peter G. Nicholls, C. Ruth Butlin, Stephen G Withington
Publikováno v:
Leprosy Review. 87:171-182
Introduction Duration of leprosy treatment remains long and difficult to complete in resource poor areas. Studies suggest that shortening duration of therapy for MB patients to 6 months may be possible. Methods New MB patients in 2005 in two NGO proj
Autor:
C Ruth, Butlin, David, Pahan, Aung Kya Jai, Maug, Stephen, Withington, Peter, Nicholls, Khorshed, Alam, M D Abdul Hamid, Salim
Publikováno v:
Leprosy review. 87(2)
Duration of leprosy treatment remains long and difficult to complete in resource poor areas. Studies suggest that shortening duration of therapy for MB patients to 6 months may be possible.New MB patients in 2005 in two NGO projects in Bangladesh wer
Autor:
Anouk van Hooij, Linda Oskam, Jan Hendrik Richardus, Annemieke Geluk, David Pahan, Louis Wilson, Susan J. F. van den Eeden, Konrad van der Zwet, Renate A. Richardus, Khorshed Alam, Roel Faber
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 11, Iss 12, p e0006083 (2017)
PLoS Neglected Tropical Diseases, 11(12)
PLoS Neglected Tropical Diseases (print), 11(12):e0006083. Public Library of Science
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, 11(12)
PLoS Neglected Tropical Diseases (print), 11(12):e0006083. Public Library of Science
PLoS Neglected Tropical Diseases
Background Despite elimination efforts, the number of Mycobacterium leprae (M. leprae) infected individuals who develop leprosy, is still substantial. Solid evidence exists that individuals living in close proximity to patients are at increased risk
Publikováno v:
Leprosy Review, 83(3), 292-304. British Leprosy Relief Association
EUR Research Portal
EUR Research Portal
The COLEP trial in Bangladesh showed a 57% reduction in leprosy incidence among contacts of newly diagnosed patients in the first 2 years after chemoprophylaxis with single dose rifampicin (SDR). We assessed the impact of this intervention after 6 ye